AstraZeneca to acquire Fusion Pharmaceuticals to boost cancer radioconjugate development

In a strategic move to revolutionize cancer treatment, AstraZeneca has announced its definitive agreement to acquire Fusion Pharmaceuticals Inc., a pioneer in the development of ... Read More